---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025714"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-05-31T23:58:22.108470+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# InspireMD completes full exercise of Series H warrants for $17.9M gross proceeds

## Summary
- Gross proceeds $17.9M; net proceeds $16.9M after fees.
- Warrants exercised after positive one-year C-GUARDIANS trial follow-up.
- Proceeds to fund CGuard Prime CAS delivery system and SwitchGuard TCAR NPS.
- Participants include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and Board members.
- First of four milestone-based tranches from May 2023 private placement of up to $113.6M.

## SEC filing metadata
- accession: 0001493152-24-025714
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315224025714/0001493152-24-025714-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315224025714/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025714
- JSON: https://secwatch.observer/filing/0001493152-24-025714.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025714.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.